Zepbound ( tirzepatide ) , which targets GLP-1 and GIP (another hormone) and led to an average weight loss of about 20% in 72 weeks
The GLP-1 agonists bind to receptors in the brain, pancreas and intestines, which helps to regulate insulin release, lower blood sugar levels, slow down digestion, and reduce appetite
Michelle Pierce, 25, is a patient from Austin who also has relied on a compounded semaglutide to treat her PCOS
Emma F, Nesterova G, Langman C, Labbe A, Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, Dohil R, Trauner D, Antignac C, Cochat P, Kaskel F, Servais A, Wuhl E, Niaudet P, Vant Hoff W, Gahl W, Levtchenko E (2014) Nephropathic cystinosis: an international consensus document